For the treatment of pulmonary diseases, countless people all over the world rely on inhalers. A large part of them are dry powder inhalers (DPIs), where the active ingredient is provided in a powder formulation. However, it is a long road with numerous obstacles before the devices can actually help patients. Powder development in particular presents many challenges.
“Pharmaceutical companies benefit from our decades of experience.”Olga Urazova,
Chief Business Development Officer
at Sterling S.P.A.
The active ingredient, excipient, mixing process, filling process or the device itself – all these aspects, and especially the interactions between them, need to be well-balanced in order to make a formulation effective and robust.
“Our services cover all critical steps involved in DPI development.”Xander van Leeuwen,
Sales Director Inhalation
at DFE Pharma
At the same time, pharmaceutical companies often outsource the individual development steps to other companies. This is why different parties are responsible for aspects such as development of the active ingredient, selection of the excipient and the appropriate dosing technology.
However, their focus is often limited to their specific expertise in the overall project. Upstream or downstream processes may only be partially taken into account and possible repercussions may simply be condoned. Failed development projects or subsequent problems during production can be the result.
“With INTO, our focus is always on the interactions between powder, filling process and inhaler.”Marco Laackmann,
Director Inhalation Technology
at Harro Höfliger
It is against this background that INTO (Inhalation Together) was born. INTO is a strategic cooperation between the active ingredient manufacturer Sterling S.P.A., the expert for excipients DFE Pharma and Harro Höfliger who is responsible for the appropriate dosing technology. Each of the companies has decades of experience in the inhalation field. The alliance helps pharmaceutical companies to make formulation development for dry powder inhalers faster, safer and more efficient.
From the very first moment, INTO can see the entire development trajectory, from the active ingredient particle to the filling line. The specialists know where the obstacles are, how to overcome them, and how to, as quickly as possible, achieve the ultimate goal – a perfect powder formulation.
Download this article as PDF file
Photos: Who is Danny/Adobe Stock